Terms And Conditions
  1. Home
  2. Terms And Conditions
Renerve Limited (ASX: RNV) – Operates with ...
By ACE Investors / 20 Dec 2024
Read More
Avita Medical Inc. (ASX: AVH) – Plan to exp...
By ACE Investors / 20 Dec 2024
Read More
INOVIQ Limited (ASX: IIQ): INOVIQ completed d...
By ACE Investors / 19 Dec 2024
Read More
NeoGenomics, Inc. (NASDAQ: NEO): EBITDA Impro...
By ACE Investors / 11 Dec 2024
Read More
Orthocell Limited (ASX: OCC): Expecting a sho...
By ACE Investors / 11 Dec 2024
Read More
Starpharma Holdings Limited (ASX: SPL) – De...
By ACE Investors / 10 Dec 2024
Read More
4DMedical Limited (ASX: 4DX) – Commercial e...
By ACE Investors / 09 Dec 2024
Read More
IQVIA Holdings Inc. (NYSE: IQV): Focused on g...
By ACE Investors / 06 Dec 2024
Read More
Novo Nordisk A/S (NYSE: NVO): Focus on Broade...
By ACE Investors / 05 Dec 2024
Read More
Clinuvel Pharmaceuticals Limited (ASX: CUV): ...
By ACE Investors / 29 Nov 2024
Read More
Myriad Genetics, Inc. (NASDAQ: MYGN): Enhanci...
By ACE Investors / 28 Nov 2024
Read More
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS): E...
By ACE Investors / 27 Nov 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors